KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to -$44.9 million.

  • Idexx Laboratories' Cash from Investing Activities fell 63.95% to -$44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$148.0 million, marking a year-over-year increase of 25.15%. This contributed to the annual value of -$207.1 million for FY2024, which is 65.31% down from last year.
  • Idexx Laboratories' Cash from Investing Activities amounted to -$44.9 million in Q3 2025, which was down 33.43% from -$33.6 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Cash from Investing Activities peaked at -$24.6 million during Q1 2021, and registered a low of -$174.7 million during Q2 2021.
  • In the last 3 years, Idexx Laboratories' Cash from Investing Activities had a median value of -$32.9 million in 2024 and averaged -$40.0 million.
  • As far as peak fluctuations go, Idexx Laboratories' Cash from Investing Activities tumbled by 611.28% in 2021, and later surged by 72.31% in 2025.
  • Over the past 5 years, Idexx Laboratories' Cash from Investing Activities (Quarterly) stood at -$44.0 million in 2021, then declined by 11.78% to -$49.2 million in 2022, then skyrocketed by 38.18% to -$30.4 million in 2023, then plummeted by 30.91% to -$39.8 million in 2024, then crashed by 63.95% to -$44.9 million in 2025.
  • Its last three reported values are -$44.9 million in Q3 2025, -$33.6 million for Q2 2025, and -$29.6 million during Q1 2025.